EUVIMEDEUVIMED entdecken
Open Access

Contrasting the reinforcing effects of the novel dopamine transport inhibitors JJC8-088 and JJC8-091 in monkeys: Potential translation to medication assisted treatment

Mia I Allen, Omeed Rahimi, Bernard N Johnson, Jianjing Cao, Amy Hauck Newman, Michael A Nader

The Journal of Pharmacology and Experimental Therapeutics · 2025

DOI: 10.1124/jpet.124.002356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2025. Verfasst von Mia I Allen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Neuroscience, Wake Forest University School of Medicine, Winston-Salem, North Carolina. Hauptthemen laut MEDLINE: Reinforcement, Psychology, Dopamine Uptake Inhibitors, Dopamine Plasma Membrane Transport Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, Intramural NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite considerable efforts, there remains no Food and Drug Administration-approved medications for cocaine use disorder. One strategy to mitigate cocaine craving and relapse is to elevate dopamine. The dopamine transport inhibitor and releaser d-amphetamine has been shown to decrease cocaine self-administration (SA), although it has abuse liability. Recently, several modafinil analogs reduced cocaine SA in rats and monkeys, including JJC8-088, characterized as "cocaine-like" in rats, and JJC8-091, characterized as "atypical" and not SA by rats. The present study evaluated the reinforcing effects of both compounds in monkeys under several conditions. For experiment 1, 4 male cocaine-experienced rhesus monkeys self-administered cocaine (0.001-0.3 mg/kg per injection), JJC8-088 (0.001-0.3 mg/kg per injection), and JJC8-091 (0.1-3.0 mg/kg per injection) under a progressive-ratio schedule of reinforcement. Both JJC compounds functioned as reinforcers with equal reinforcing strength to cocaine. Although JJC8-091 was less potent than cocaine, JJC8-088 and cocaine had similar potencies. For experiment 2, 1 male and 2 female drug-naïve cynomolgus monkeys responded on a fixed-ratio schedule of food reinforcement. JJC8-091 was self-administered at rates higher than saline in all 3 monkeys. In experiment 3, monkeys from experiment 2 responded under a concurrent drug versus food choice paradigm and given access to cocaine or JJC8-091 under these conditions. At doses equal to or one-half log-units higher than doses used in experiment 2, cocaine, but not JJC8-091, was chosen over food. Together, these results demonstrate that although JJC8-091 may be reinforcing under some conditions, its reinforcing strength, in the presence of an alternative reinforcer, is substantially less than cocaine. SIGNIFICANCE STATEMENT: JJC8-088 and JJC8-091 have shown efficacy is reducing cocaine self-administration (SA) in rats and in nonhuman primates. This study found that both compounds maintained SA in monkeys responding under several conditions. However, when given access to an alternative reinforcer during the SA session, JJC8-091 was not reinforcing, suggesting that JJC8-091 may have lower abuse liability than cocaine and may be a viable candidate for cocaine use disorder because, in the human population, alternatives to drug use are often available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reinforcement, PsychologyDopamine Uptake InhibitorsDopamine Plasma Membrane Transport ProteinsAnimalsMaleSelf AdministrationMacaca mulattaCocaineDose-Response Relationship, DrugCocaine-Related Disorders

Stichwörter der Autor:innen

AcquisitionCocaineDopamine transporterMonkeyReinforcing strengthSelf-administration

Substanzen

CocaineDopamine Uptake InhibitorsDopamine Plasma Membrane Transport Proteins

Autor:innen und Institutionen

  • Department of Translational Neuroscience, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
  • Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse-Intramural Research Program, National Institutes of Health, Baltimore, Maryland.
  • Department of Translational Neuroscience, Wake Forest University School of Medicine, Winston-Salem, North Carolina. Electronic address: mnader@wakehealth.edu.

Förderung

  • NIDA NIH HHS
  • Intramural NIH HHS
  • National Institutes of Health
  • National Institute on Drug Abuse

Zitieren

APA

Allen, M. I., Rahimi, O., Johnson, B. N., Cao, J., Newman, A. H., & Nader, M. A. (2025). Contrasting the reinforcing effects of the novel dopamine transport inhibitors JJC8-088 and JJC8-091 in monkeys: Potential translation to medication assisted treatment. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.124.002356

Vancouver

Allen MI, Rahimi O, Johnson BN, Cao J, Newman AH, Nader MA. Contrasting the reinforcing effects of the novel dopamine transport inhibitors JJC8-088 and JJC8-091 in monkeys: Potential translation to medication assisted treatment. The Journal of Pharmacology and Experimental Therapeutics. 2025. doi:10.1124/jpet.124.002356

BibTeX
@article{Allen2025,
  author = {Allen, Mia I and Rahimi, Omeed and Johnson, Bernard N and Cao, Jianjing and Newman, Amy Hauck and Nader, Michael A},
  title = {Contrasting the reinforcing effects of the novel dopamine transport inhibitors JJC8-088 and JJC8-091 in monkeys: Potential translation to medication assisted treatment},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  year = {2025},
  doi = {10.1124/jpet.124.002356}
}
Kostenlos starten →